MNMs designed for systemic delivery

To date, delivery limitations kept the vast majority of RNA medicines in the liver. Aposense's Molecular Nano-Motors are designed to bind to albumin thus utilizing the circulation as carrier. Accordingly (as seen in the figure) Our constructs extend widely beyond the liver into various organs and reaches systemic like distribution. This breakthrough holds the potential unlock novel targets for genetic therapeutics.